Skip to main content
PMC home page
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2007 Sep;68(5):313–324. doi: 10.1016/j.curtheres.2007.10.006

Effect of Dexmedetomidine IV on the Duration of Spinal Anesthesia with Prilocaine: A Double-Blind, Prospective Study in Adult Surgical Patients

Murat Tekin 1,a, Ismail Kati 1, Yakup Tomak 1, Erol Kisli 2
PMCID: PMC3969905  PMID: 24692763

Abstract

Background: The duration of spinal anesthesia with prilocaine has been poorly documented and no English-language study has been published regarding the effects of dexmedetomidine on the duration of anesthesia with spinal prilocaine.

Objective: The aim of this study was to assess the effects of dexmedetomidine IV on the duration of action of prilocaine and its associated adverse events (AEs) in spinal anesthesia.

Methods: In this double-blind, prospective study, patients classified as American Society of Anesthesiologists grade I to II who were to undergo lower abdominal, anorectal, or extremity surgery with a spinal anesthetic were assigned to 1 of 2 groups. All patients were administered prilocaine 2% for spinal anesthesia. Within 10 minutes after spinal anesthesia was initiated, group 1 received a loading dose of dexmedetomidine 1 μg/kg IV, followed by a maintenance dose of 0.4 μg/kg · h for 50 minutes; group 2 (control) received the same amount of physiologic saline in the same time frame. Mean arterial pressure (MAP), heart rate (HR), duration of sensory and motor blockade, and sedation scores were tracked. Patients were observed for 4.5 hours after surgery, with follow-ups occurring up to 96 hours after surgery.

Results: Eighty-three patients were assessed for study inclusion, 23 of whom were excluded. Sixty patients (42 men, 18 women; mean [SD] age, 40.56 [16.86] years) were included in the study. MAP was similar in the 2 groups throughout the study. Mean (SD) HR was significantly lower in group 1 compared with group 2 at 20 minutes (70.43 [19.28] vs 77.63 [18.14] beats per minute, respectively; P = 0.02). The mean (SD) duration of the persistence of sensory anesthesia (ie, the time required for the maximal level of anesthesia to regress 2 dermatomes) was significantly longer in group 1 compared with group 2 (148.33 [21.18] vs 122.83 [18.73] minutes; P < 0.001). The mean (SD) time to complete abolishment of motor blockade was also significantly longer in group 1 than in group 2 (215.16 [25.10] vs 190.83 [18.57] minutes; P < 0.001). The average sedation score in group 1 was significantly higher than in group 2 (P < 0.001) during anesthesia. Significantly more patients in group 1 required atropine than those in group 2 (9 vs 2 patients; P < 0.001) to treat bradycardia. There was no significant between-group difference in the number of patients who received ephedrine to treat hypotension. One patient in each group reported waist and back pain; 2 patients in each group reported nausea. Shivering occurred in 0 and 5 patients in groups 1 and 2, respectively; the between-group difference in AEs was not statistically significant. Paresthesia, postdural puncture headache, allergic reactions, total spinal anesthesia, urinary retention, or vomiting—AEs commonly associated with spinal anesthesia—were not observed or reported by either group.

Conclusions: The results of this study suggest that dexmedetomidine IV significantly prolonged the duration of spinal anesthesia and provided a significantly higher level of sedation compared to placebo in this group of adult surgical patients. The treatment was generally well tolerated in all patients.

Keywords: dexmedetomidine, prilocaine, spinal anesthesia

Full Text

The Full Text of this article is available as a PDF (684.3 KB).

References

  • 1.Brown DL. In: Spinal, epidural and caudal anesthesia. Miller RD, editor. Philadelphia, Pa: Churchill Livingstone; Anesthesia: 2000. pp. 1492–1498. [Google Scholar]
  • 2.Bernard CM. Epidural and spinal anesthesia. In: Barash PG, editor. Clinical Anesthesia. Pa: Lippincott Williams & Wilkins; Philadelphia: 2001. pp. 645–668. [Google Scholar]
  • 3.Rhee K, Kang K, Kim J, Jeon Y. Intravenous clonidine prolongs bupivacaine spinal anesthesia. Acta Anaesthesiol Scand. 2003;47:1001–1005. doi: 10.1034/j.1399-6576.2003.00158.x. [DOI] [PubMed] [Google Scholar]
  • 4.Kanazi GE, Aouad MT, Jabbour-Khoury SI. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand. 2006;50:222–227. doi: 10.1111/j.1399-6576.2006.00919.x. [DOI] [PubMed] [Google Scholar]
  • 5.American Society of Anesthesiologists (ASA). ASA Physical Status Classification System [ASA Web site],; September 9, 2007. http://www.asahq.org/clinical/physicalstatus.htm Accessed.
  • 6.World Medical Association Declaration of Helsinki: Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects [WMA Web site]. Ferney-Voltaire, France: WMA; 1989.; September 9, 2007. http://www.wma.net Accessed.
  • 7.European Agency for the Evaluation of Medicinal Products, International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice [EMEA Web site]. ICH Topic E6. Geneva, Switzerland: WHO; 2002.; September 9, 2007.. http://www.emea.eu.int Accessed.
  • 8.US Food and Drug Administration [FDA web site],; September 9, 2007. http://www.fda.gov/cder/foi/label/2001/21038S11bl.pdf Accessed.
  • 9.Dawson C, Ma D, Chow A, Maze M. Dexmedetomidine enhances analgesic action of nitrous oxide: Mechanisms of action. Anesthesiology. 2004;100:894–904. doi: 10.1097/00000542-200404000-00020. [DOI] [PubMed] [Google Scholar]
  • 10.Ramsay MA, Savege TM, Simpson BRJ, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2:656–659. doi: 10.1136/bmj.2.5920.656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Pouttu J, Scheinin B, Rosenberg PH. Oral premedication with clonidine: Effects on stress responses during general anaesthesia. Acta Anaesthesiol Scand. 1987;31:730–734. doi: 10.1111/j.1399-6576.1987.tb02654.x. [DOI] [PubMed] [Google Scholar]
  • 12.Almeida RA, Lauretti GR, Mattos AL. Antinociceptive effect of low-dose intrathecal neostigmine combined with intrathecal morphine following gynecologic surgery. Anesthesiology. 2003;98:495–498. doi: 10.1097/00000542-200302000-00031. [DOI] [PubMed] [Google Scholar]
  • 13.Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: Defining the role in clinical anesthesia. Anesthesiology. 1991;74:581–605. [PubMed] [Google Scholar]
  • 14.Mikawa K, Nishina K, Maekawa N, Obara H. Oral clonidine premedication reduces postoperative pain in children. Anesth Analg. 1996;82:225–230. doi: 10.1097/00000539-199602000-00001. [DOI] [PubMed] [Google Scholar]
  • 15.Weinbroum AA, Ben-Abraham R. Dextromethorphan and dexmedetomidine: New agents for the control of perioperative pain. Eur J Surg. 2001;167:563–569. doi: 10.1080/110241501753171146. [DOI] [PubMed] [Google Scholar]
  • 16.Choyce A, Peng P. A systematic review of adjuncts for intravenous regional anesthesia for surgical procedures. Can J Anaesth. 2002;49:32–45. doi: 10.1007/BF03020416. [DOI] [PubMed] [Google Scholar]
  • 17.Memis D, Turan A, Karamanlioglu B. Adding dexmedetomidine to lidocaine for intravenous regional anesthesia. Anesth Analg. 2004;98:835–840. doi: 10.1213/01.ane.0000100680.77978.66. [DOI] [PubMed] [Google Scholar]
  • 18.Jaakola ML. Dexmedetomidine premedication before intravenous regional anesthesia in minor outpatient hand surgery. J Clin Anesth. 1994;6:204–211. doi: 10.1016/0952-8180(94)90060-4. [DOI] [PubMed] [Google Scholar]
  • 19.Lurie SD, Reuben SS, Gibson CS. Effect of clonidine on upper extremity tourniquet pain in healthy volunteers. Reg Anesth Pain Med. 2000;25:502–505. doi: 10.1053/rapm.2000.8460. [DOI] [PubMed] [Google Scholar]
  • 20.Crankshaw TP. Citanest (prilocaine) in spinal analgesia. Acta Anaesthesiol Scand. 1965;16(Suppl):287–290. doi: 10.1111/j.1399-6576.1965.tb00552.x. [DOI] [PubMed] [Google Scholar]
  • 21.Ostgaard G, Hallaraker O, Ulveseth OK, Flaatten H. A randomised study of lidocaine and prilocaine for spinal anaesthesia. Acta Anaesthesiol Scand. 2000;44:436–440. doi: 10.1034/j.1399-6576.2000.440413.x. [DOI] [PubMed] [Google Scholar]
  • 22.de Weert K, Traksel M, Gielen M. The incidence of transient neurological symptoms after spinal anaesthesia with lidocaine compared to prilocaine. Anaesthesia. 2000;55:1020–1024. doi: 10.1046/j.1365-2044.2000.01618-4.x. [DOI] [PubMed] [Google Scholar]
  • 23.Kallio A, Scheinin M, Koulu M. Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther. 1989;46:33–42. doi: 10.1038/clpt.1989.103. [DOI] [PubMed] [Google Scholar]
  • 24.Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992;77:1134–1142. doi: 10.1097/00000542-199212000-00014. [DOI] [PubMed] [Google Scholar]
  • 25.Mantz J. Dexmedetomidine. Drugs Today (Barc) 1999;35:151–157. doi: 10.1358/dot.1999.35.3.533844. [DOI] [PubMed] [Google Scholar]
  • 26.Carpenter RL, Caplan RA, Brown DL. Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology. 1992;76:906–916. doi: 10.1097/00000542-199206000-00006. [DOI] [PubMed] [Google Scholar]
  • 27.Gentili M, Huu PC, Enel D. Sedation depends on the level of sensory block induced by spinal anesthesia. Br J Anaesth. 1998;81:970–971. doi: 10.1093/bja/81.6.970. [DOI] [PubMed] [Google Scholar]
  • 28.Pollock JE, Neal JM, Liu SS. Sedation during spinal anesthesia. Anesthesiology. 2000;93:728–734. doi: 10.1097/00000542-200009000-00022. [DOI] [PubMed] [Google Scholar]
  • 29.Kati I, Demirel CB, Abbasov ÜH. Igne tipinin spinal anestezi komplikasyonlarl üzerine etkileri. Van Tip Dergisi. 2002;9:47–51. [Google Scholar]
  • 30.Tarkkila PJ, Heine H, Tervo RR. Comparison of Sprotte and Quincke needles with respect to post dural puncture headache and backache. Reg Anesth. 1992;17:283–287. [PubMed] [Google Scholar]
  • 31.Lynch J, Arhelger S, Krings-Ernst I. Post-dural puncture headache in young orthopaedic in-patients: Comparison of a 0.33 mm (29-gauge) Quincke-type with a 0.7 mm (22-gauge) Whitacre spinal needle in 200 patients. Acta Anaesthesiol Scand. 1992;36:58–61. doi: 10.1111/j.1399-6576.1992.tb03422.x. [DOI] [PubMed] [Google Scholar]
  • 32.Vassilieff N, Rosencher N, Sessler DI, Conseiller C. Shivering threshold during spinal anesthesia is reduced in elderly patients. Anesthesiology. 1995;83:1162–1166. doi: 10.1097/00000542-199512000-00005. [DOI] [PubMed] [Google Scholar]
  • 33.Sessler DI. Perianesthetic thermoregulation and heat balance in humans. FASEB J. 1993;7:638–644. doi: 10.1096/fasebj.7.8.8500688. [DOI] [PubMed] [Google Scholar]

Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES